Elevance Health, Inc. (ELV) shareholders
Close on Nov 17, 2026Market cap $93.75BP/E 18.5Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 17,694,658 | 7.80% | 13G (passive) amendment | Mar 31, 2025 |
| Vanguard Capital Management | 16,601,224 | 7.13% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ELV | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 18,991,090 | 8.79% | $7.34B | −896,021 | 0.11% |
| Vanguard Capital Management LLC | 14,058,204 | 6.51% | $5.44B | −287,255 | 0.12% |
| State Street Corp | 10,426,610 | 4.83% | $4.03B | +137,914 | 0.12% |
| Wellington Management Group Llp | 9,213,513 | 4.26% | $3.56B | +984,976 | 0.61% |
| First Eagle Investment Management, LLC | 8,376,392 | 3.88% | $3.24B | +4,244,101 | 2.68% |
| Vanguard Portfolio Management LLC | 6,214,356 | 2.88% | $2.40B | −141,721 | 0.11% |
| Sanders Capital, LLC | 5,825,024 | 2.70% | $2.25B | −69,279 | 2.26% |
| Geode Capital Management, LLC | 5,166,124 | 2.39% | $1.99B | −26,583 | 0.11% |
| Harris Associates L P | 4,924,511 | 2.28% | $1.90B | +127,985 | 2.53% |
| Artisan Partners Limited Partnership | 4,581,222 | 2.12% | $1.77B | −545,953 | 2.81% |
| Invesco Ltd. | 4,234,231 | 1.96% | $1.64B | −583,179 | 0.13% |
| Price T Rowe Associates Inc /Md/ | 4,014,991 | 1.86% | $1.55B | −731,594 | 0.16% |
| Norges Bank | 3,958,856 | 1.83% | $1.53B | New | 0.15% |
| Bank of New York Mellon Corp | 3,222,787 | 1.49% | $1.25B | +377,507 | 0.20% |
| FMR LLC | 3,131,652 | 1.45% | $1.21B | +1,155,933 | 0.05% |
| Morgan Stanley | 2,605,764 | 1.21% | $1.01B | −23,340 | 0.05% |
| Northern Trust Corp | 2,114,986 | 0.98% | $817.93M | −43,039 | 0.10% |
| Citigroup Inc | 2,096,863 | 0.97% | $810.92M | +1,858,013 | 0.27% |
| UBS Asset Management Americas Inc | 2,065,537 | 0.96% | $798.81M | −453,078 | 0.15% |
| Hotchkis & Wiley Capital Management LLC | 2,016,200 | 0.93% | $779.73M | −175,363 | 2.27% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,604 | 204M | 94.3% | 263 / 594 | 545 / 104 | 26M | 16M |
| Q1 2026 | 1,470 | 195M | 90.2% | 146 / 483 | 647 / 210 | 36M | 20M |
| Q4 2025 | 1,554 | 203M | 93.9% | 222 / 501 | 614 / 152 | 20M | 14M |
| Q3 2025 | 1,511 | 198M | 91.5% | 166 / 534 | 607 / 226 | 19M | 26M |
| Q2 2025 | 1,593 | 206M | 95.3% | 144 / 600 | 604 / 188 | 15M | 13M |
| Q1 2025 | 1,663 | 205M | 94.9% | 219 / 652 | 540 / 135 | 16M | 16M |
| Q4 2024 | 1,604 | 208M | 96.3% | 222 / 473 | 735 / 285 | 24M | 25M |
| Q3 2024 | 1,699 | 210M | 97.0% | 137 / 680 | 603 / 129 | 31M | 12M |
| Q2 2024 | 1,709 | 211M | 97.5% | 148 / 713 | 551 / 87 | 9M | 13M |
| Q1 2024 | 1,669 | 216M | 100.0% | 159 / 670 | 548 / 123 | 13M | 10M |
| Q4 2023 | 1,657 | 213M | 98.8% | 242 / 598 | 591 / 86 | 15M | 10M |
| Q3 2023 | 1,526 | 208M | 96.2% | 117 / 576 | 572 / 98 | 10M | 12M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
950 funds held ELV in Q2 2026, 41% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ELV | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 6,607,886 | 3.06% | $2.56B | 0.11% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 5,390,387 | 2.49% | $2.08B | 0.12% | Jun 30, 2026 |
| Vanguard Windsor Ii Fund | 3,038,771 | 1.41% | $1.14B | 1.71% | Jul 31, 2026 |
| iShares Core S&P 500 ETF | 2,986,829 | 1.38% | $1.16B | 0.13% | Jun 30, 2026 |
| First Eagle Global Fund | 2,844,869 | 1.32% | $1.07B | 1.41% | Jul 31, 2026 |
| Fidelity 500 Index Fund | 2,824,366 | 1.31% | $1.11B | 0.13% | May 31, 2026 |
| Vanguard Equity Income Fund | 2,046,234 | 0.95% | $791.34M | 1.21% | Jun 30, 2026 |
| Vanguard Value Index Fund | 2,023,286 | 0.94% | $782.47M | 0.31% | Jun 30, 2026 |
| Vanguard Health Care Fund | 1,858,361 | 0.86% | $698.45M | 1.83% | Jul 31, 2026 |
| Oakmark Fund | 1,705,000 | 0.79% | $659.37M | 2.74% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 1,534,224 | 0.71% | $593.33M | 1.46% | Jun 30, 2026 |
| MFS Value Fund | 1,395,797 | 0.65% | $548.81M | 1.07% | May 31, 2026 |
| Vanguard Dividend Growth Fund | 1,261,543 | 0.58% | $474.14M | 1.34% | Jul 31, 2026 |
| Vanguard Dividend Appreciation Index Fund | 1,201,951 | 0.56% | $451.74M | 0.35% | Jul 31, 2026 |
| Vanguard Institutional Index Fund | 1,129,281 | 0.52% | $436.73M | 0.12% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Gail Boudreaux | President and CEO, Director | 172,036 | 0.08% | Jul 17, 2026 |
| Ratnakar Lavu | EVP & Chief Digital Info Ofr | 14,849 | 0.01% | Nov 6, 2026 |
| Mark Kaye | EVP & CFO | 19,919 | 0.01% | Oct 23, 2026 |
| Erin M. Wessling | EVP & Chief Legal Officer | 7,230 | 0.00% | Sep 4, 2026 |
| Ryan R. Craig | EVP & Chief HR Officer | 6,530 | 0.00% | Sep 4, 2026 |
| Ronald W. Penczek | CAO & Controller | 3,740 | 0.00% | Jun 15, 2026 |
| Charles Morgan Kendrick JR | EVP & President, Commercial | 11,791 | 0.01% | Mar 9, 2026 |
| Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | 27,222 | 0.01% | Mar 4, 2026 |
| Felicia F. Norwood | EVP &Chief Health Benefits Ofr | 38,838 | 0.02% | Mar 4, 2026 |
| Blair Williams Todt | EVP, CLO & CAO | 15,631 | 0.01% | Jan 7, 2025 |
| Ramiro G. Peru | Director | 10,908 | 0.01% | Jul 17, 2026 |
| Robert L. Dixon JR | Director | 10,734 | 0.00% | Jun 12, 2026 |
| Amy W. Schulman | Director | 781 | 0.00% | May 15, 2026 |
| Antonio F. Neri | Director | 5,488 | 0.00% | May 15, 2026 |
| Ryan M. Schneider | Director | 7,163 | 0.00% | May 15, 2026 |
| Lewis Hay Iii | Director | 12,070 | 0.01% | May 15, 2026 |
| Steven H. Collis | Director | 4,202 | 0.00% | May 15, 2026 |
| Deanna D. Strable-Soethout | Director | 2,209 | 0.00% | May 15, 2026 |
| Susan D. DeVore | Director | 4,065 | 0.00% | May 15, 2026 |
| Bahija Jallal | Director | 5,351 | 0.00% | May 15, 2026 |
| R. Kerry Clark | Director | 9,640 | 0.00% | May 16, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ratnakar Lavu EVP & Chief Digital Info Ofr | Nov 5, 2026 | Sale | −1,300 | $440.00 | $572.00K | 14,849 |
| Mark Kaye EVP & CFO | Oct 22, 2026 | Sale | −273 | $447.19 | $122.08K | 19,919 |
| Mark Kaye EVP & CFO | Oct 22, 2026 | Sale | −827 | $446.05 | $368.88K | 20,192 |
| Mark Kaye EVP & CFO | Oct 22, 2026 | Sale | −160 | $444.85 | $71.18K | 21,019 |
| Mark Kaye EVP & CFO | Oct 22, 2026 | Sale | −440 | $443.81 | $195.28K | 21,179 |
| Mark Kaye EVP & CFO | Oct 22, 2026 | Sale | −480 | $442.61 | $212.45K | 21,619 |
| Mark Kaye EVP & CFO | Oct 22, 2026 | Sale | −2,343 | $441.34 | $1.03M | 22,099 |
| Mark Kaye EVP & CFO | Oct 22, 2026 | Sale | −1,720 | $440.44 | $757.56K | 24,442 |
| Mark Kaye EVP & CFO | Oct 22, 2026 | Sale | −1,160 | $439.25 | $509.53K | 26,162 |
| Mark Kaye EVP & CFO | Oct 22, 2026 | Sale | −240 | $438.22 | $105.17K | 27,322 |
| Mark Kaye EVP & CFO | Oct 22, 2026 | Sale | −560 | $437.07 | $244.76K | 27,562 |
| Mark Kaye EVP & CFO | Oct 22, 2026 | Sale | −1,660 | $436.20 | $724.09K | 28,122 |
| Mark Kaye EVP & CFO | Oct 22, 2026 | Sale | −321 | $435.25 | $139.72K | 29,782 |
| Mark Kaye EVP & CFO | Oct 22, 2026 | Sale | −400 | $434.00 | $173.60K | 30,103 |
| Mark Kaye EVP & CFO | Oct 2, 2026 | Award | +2,627 | – | – | 30,503 |
| Mark Kaye EVP & CFO | Oct 2, 2026 | Tax withholding | −4,161 | $386.43 | $1.61M | 27,876 |
| Erin M. Wessling EVP & Chief Legal Officer | Sep 3, 2026 | Tax withholding | −255 | $414.78 | $105.77K | 7,230 |
| Erin M. Wessling EVP & Chief Legal Officer | Sep 2, 2026 | Tax withholding | −94 | $405.84 | $38.15K | 7,485 |
| Ryan R. Craig EVP & Chief HR Officer | Sep 2, 2026 | Tax withholding | −144 | $405.84 | $58.44K | 6,530 |
| Ramiro G. Peru Director | Jul 17, 2026 | Buy | +1,000 | $366.05 | $366.05K | 10,908 |
| Gail Boudreaux President and CEO, Director | Jul 17, 2026 | Buy | +2,045 | $368.25 | $753.07K | 171,976 |
| Gail Boudreaux President and CEO, Director | Jul 17, 2026 | Buy | +680 | $366.41 | $249.16K | 169,931 |
| Ronald W. Penczek CAO & Controller | Jun 12, 2026 | Sale | −369 | $403.16 | $148.77K | 3,740 |
| Robert L. Dixon JR Director | Jun 11, 2026 | Sale | −151 | $401.77 | $60.67K | 10,734 |
| Ronald W. Penczek CAO & Controller | May 19, 2026 | Option exercise | +654 | $271.27 | $177.41K | 4,763 |
| Ronald W. Penczek CAO & Controller | May 19, 2026 | Sale | −1,531 | $403.13 | $617.19K | 4,109 |
| Ronald W. Penczek CAO & Controller | May 19, 2026 | Option exercise | +877 | $311.48 | $273.17K | 5,640 |
| Ramiro G. Peru Director | May 13, 2026 | Award | +563 | – | – | 9,908 |
| Ryan M. Schneider Director | May 13, 2026 | Award | +563 | – | – | 7,163 |
| Susan D. DeVore Director | May 13, 2026 | Award | +563 | – | – | 4,065 |
| Antonio F. Neri Director | May 13, 2026 | Award | +563 | – | – | 5,488 |
| Lewis Hay Iii Director | May 13, 2026 | Award | +563 | – | – | 12,070 |
| Robert L. Dixon JR Director | May 13, 2026 | Award | +563 | – | – | 10,885 |
| Deanna D. Strable-Soethout Director | May 13, 2026 | Award | +563 | – | – | 2,209 |
| Bahija Jallal Director | May 13, 2026 | Award | +563 | – | – | 5,351 |
| Amy W. Schulman Director | May 13, 2026 | Award | +563 | – | – | 781 |
| Steven H. Collis Director | May 13, 2026 | Award | +563 | – | – | 4,202 |
| Amy W. Schulman Director | Mar 12, 2026 | Sale | −26 | $287.50 | $7.48K | 218 |
| Charles Morgan Kendrick JR EVP & President, Commercial | Mar 6, 2026 | Sale | −3,196 | $284.92 | $910.60K | 11,791 |
| Steven H. Collis Director | Mar 5, 2026 | Buy | +3,000 | $289.84 | $869.52K | 3,639 |
| Charles Morgan Kendrick JR EVP & President, Commercial | Mar 3, 2026 | Tax withholding | −467 | $284.03 | $132.64K | 14,987 |
| Gail Boudreaux President and CEO, Director | Mar 3, 2026 | Tax withholding | −1,736 | $284.03 | $493.08K | 169,251 |
| Ryan R. Craig EVP & Chief HR Officer | Mar 3, 2026 | Tax withholding | −309 | $284.03 | $87.77K | 6,674 |
| Ratnakar Lavu EVP & Chief Digital Info Ofr | Mar 3, 2026 | Tax withholding | −222 | $284.03 | $63.05K | 16,149 |
| Peter D. Haytaian EVP & Pres Carelon & CarelonRx | Mar 3, 2026 | Tax withholding | −446 | $284.03 | $126.68K | 27,222 |
| Erin M. Wessling EVP & Chief Legal Officer | Mar 3, 2026 | Tax withholding | −417 | $284.03 | $118.44K | 7,579 |
| Felicia F. Norwood EVP &Chief Health Benefits Ofr | Mar 3, 2026 | Tax withholding | −496 | $284.03 | $140.88K | 38,838 |
| Ronald W. Penczek CAO & Controller | Mar 3, 2026 | Tax withholding | −37 | $284.03 | $10.51K | 4,099 |
| Mark Kaye EVP & CFO | Mar 3, 2026 | Tax withholding | −353 | $284.03 | $100.26K | 32,037 |
| Charles Morgan Kendrick JR EVP & President, Commercial | Mar 2, 2026 | Award | +2,532 | – | – | 15,454 |
| Charles Morgan Kendrick JR EVP & President, Commercial | Mar 2, 2026 | Award | +4,017 | – | – | 12,922 |
| Charles Morgan Kendrick JR EVP & President, Commercial | Mar 2, 2026 | Tax withholding | −1,211 | $294.07 | $356.12K | 8,905 |
| Gail Boudreaux President and CEO, Director | Mar 2, 2026 | Award | +10,527 | – | – | 170,987 |
| Gail Boudreaux President and CEO, Director | Mar 2, 2026 | Award | +16,153 | – | – | 160,460 |
| Gail Boudreaux President and CEO, Director | Mar 2, 2026 | Tax withholding | −6,713 | $294.07 | $1.97M | 144,307 |
| Ryan R. Craig EVP & Chief HR Officer | Mar 2, 2026 | Tax withholding | −25 | $294.07 | $7.35K | 4,007 |
| Ryan R. Craig EVP & Chief HR Officer | Mar 2, 2026 | Award | +2,976 | – | – | 6,983 |
| Ratnakar Lavu EVP & Chief Digital Info Ofr | Mar 2, 2026 | Award | +6,802 | – | – | 16,371 |
| Ratnakar Lavu EVP & Chief Digital Info Ofr | Mar 2, 2026 | Tax withholding | −315 | $294.07 | $92.63K | 4,468 |
| Ratnakar Lavu EVP & Chief Digital Info Ofr | Mar 2, 2026 | Award | +5,101 | – | – | 9,569 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Elevance Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 3,230 shares on Oct 8, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Ratnakar Lavu Officer | Nov 5, 2026 | 1,300 | $572.00K | Nov 5, 2026 | Restricted Stock |
| Mark Kaye Officer | Oct 22, 2026 | 10,584 | $4.66M | Oct 22, 2026 | Restricted Stock |
| R. Kerry Clark Director | Jul 7, 2026 | 1,500 | $629.87K | Jul 7, 2026 | Stock Award |
| Ronald W. Penczek Officer | Jun 12, 2026 | 369 | $148.77K | Jun 12, 2026 | Restricted Stock |
| Robert L. Dixon JR Director | Jun 11, 2026 | 151 | $60.67K | Jun 11, 2026 | BOD COMPENSATION |
| Ronald W. Penczek Officer | May 19, 2026 | 1,531 | $617.19K | May 19, 2026 | Stock Option Exercise |
| Charles Morgan Kendrick JR Officer | Mar 6, 2026 | 3,196 | $910.59K | Mar 6, 2026 | Restricted Stock |
| Mark Kaye Officer | Apr 24, 2025 | 4,588 | $1.95M | Apr 24, 2025 | RESTRICTED STOCK |
| Ronald W. Penczek Officer | Mar 10, 2025 | 443 | $183.90K | Mar 10, 2025 | RESTRICTED STOCK |
| Charles Morgan Kendrick JR Officer | Mar 5, 2025 | 3,504 | $1.39M | Mar 5, 2025 | RESTRICTED STOCK |
| Charles Morgan Kendrick JR Director | Oct 18, 2024 | 7,417 | $3.21M | Oct 18, 2024 | Stock Award |
| Ramiro G. Peru Director | Aug 5, 2024 | 753 | $400.23K | Aug 5, 2024 | Restricted Stock |
| Gail Boudreaux Officer, Director | Jul 22, 2024 | 34,000 | $17.03M | Jul 22, 2024 | Performance Shares |
| Robert L. Dixon JR Director | Jul 19, 2024 | 305 | $154.56K | Jul 19, 2024 | Performance Stock Units |
| Felicia F. Norwood Officer | Apr 23, 2024 | 20,310 | $10.84M | Apr 23, 2024 | STOCK OPTION EXERCISE |
Congress trades
40 trades in Elevance Health reported by 14 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Lisa McClain MI09 · spouse | Sold | Aug 13, 2025 | $1K–15K | Sep 12, 2025 |
| Gilbert Cisneros CA31 | Bought | Aug 5, 2025 | $1K–15K | Sep 12, 2025 |
| Lisa McClain MI09 · spouse | Bought | Jul 10, 2025 | $1K–15K | Aug 13, 2025 |
| Lisa McClain MI09 · spouse | Bought | Jun 24, 2025 | $1K–15K | Aug 13, 2025 50 days late |
| Gilbert Cisneros CA31 | Sold | May 30, 2025 | $1K–15K | Jun 6, 2025 |
| Rob Bresnahan PA08 | Sold | May 15, 2025 | $15K–50K | May 31, 2025 |
| Jefferson Shreve IN06 | Sold | May 12, 2025 | $15K–50K | Jun 22, 2025 |
| Gilbert Cisneros CA31 | Bought | Apr 29, 2025 | $1K–15K | May 6, 2025 |
| Dan Newhouse WA04 · spouse | Sold (part) | Apr 11, 2025 | $1K–15K | May 16, 2025 |
| Jared Moskowitz FL23 | Sold | Mar 10, 2025 | $1K–15K | Apr 8, 2025 |
| Jared Moskowitz FL23 · child | Sold | Mar 10, 2025 | $1K–15K | Apr 8, 2025 |
| Jared Moskowitz FL23 · child | Sold | Mar 10, 2025 | $1K–15K | Apr 8, 2025 |
| Jefferson Shreve IN06 | Bought | Feb 24, 2025 | $15K–50K | Mar 9, 2025 |
| Valerie Hoyle OR04 · spouse | Sold | Jan 13, 2025 | $1K–15K | Sep 12, 2025 242 days late |
| Rob Bresnahan PA08 · joint account | Sold | Jan 13, 2025 | $1K–15K | Feb 13, 2025 |
| Michael T. McCaul TX10 · spouse | Sold | Jan 9, 2025 | $15K–50K | Feb 11, 2025 |
| Jared Moskowitz FL23 · child | Bought | Nov 8, 2024 | $1K–15K | Dec 9, 2024 |
| Valerie Hoyle OR04 · spouse | Bought | Oct 29, 2024 | $1K–15K | Sep 12, 2025 318 days late |
| John James MI10 | Sold | Sep 4, 2024 | $1K–15K | Sep 6, 2024 |
| Jared Moskowitz FL23 · child | Bought | Jul 5, 2024 | $1K–15K | Aug 6, 2024 |
| Jared Moskowitz FL23 · child | Bought | Jul 1, 2024 | $1K–15K | Aug 6, 2024 |
| Dan Newhouse WA04 · spouse | Bought | Apr 10, 2024 | $1K–15K | Apr 25, 2024 |
| Jared Moskowitz FL23 | Bought | Feb 13, 2024 | $1K–15K | Aug 21, 2024 190 days late |
| Jared Moskowitz FL23 | Bought | Feb 1, 2024 | $1K–15K | Aug 21, 2024 202 days late |
| Jared Moskowitz FL23 · child | Bought | Feb 1, 2024 | $1K–15K | Aug 6, 2024 187 days late |
| Rohit Khanna CA17 · child | Bought | Dec 5, 2023 | $1K–15K | Jan 4, 2024 |
| John Curtis UT03 · joint account | Sold | Dec 4, 2023 | $1K–15K | Dec 15, 2023 |
| John James MI10 | Bought | Nov 16, 2023 | $1K–15K | Sep 2, 2024 291 days late |
| John James MI10 | Bought | Nov 10, 2023 | $1K–15K | Sep 2, 2024 297 days late |
| Greg Stanton AZ04 · spouse | Sold | Oct 24, 2023 | $1K–15K | Nov 9, 2023 |
| Michael T. McCaul TX10 · spouse | Bought | Sep 29, 2023 | $1K–15K | Oct 18, 2023 |
| Greg Stanton AZ04 · spouse | Bought | Sep 26, 2023 | $1K–15K | Nov 9, 2023 |
| Rick Larsen WA02 | Sold | Jul 5, 2023 | $1K–15K | Jul 17, 2023 |
| John Curtis UT03 · joint account | Bought | Apr 26, 2023 | $1K–15K | May 10, 2023 |
| Rick Larsen WA02 | Bought | Jan 6, 2023 | $1K–15K | May 26, 2023 140 days late |
| Robert J. Wittman VA01 | Sold (part) | Jan 3, 2023 | $1K–15K | Feb 15, 2023 |
| John Curtis UT03 · joint account | Sold | Dec 20, 2022 | $1K–15K | Jan 10, 2023 |
| Rohit Khanna CA17 | Sold | Aug 8, 2022 | $1K–15K | Apr 7, 2022 |
| John Curtis UT03 | Sold | Mar 9, 2022 | $1K–15K | Aug 7, 2023 516 days late |
| John Curtis UT03 · joint account | Sold (part) | Mar 9, 2022 | $1K–15K | Mar 23, 2022 |
See a number that looks wrong?